Target intelligence / Profile preview

Urocanic acid isomerization

Molecular classification
Other (chemical process), Isomerase-catalyzed reaction (in microorganisms)[3][6]
01

Overview

Urocanic acid isomerization" refers to the **conversion between the trans and cis forms of urocanic acid**, a naturally occurring metabolite found predominantly in the stratum corneum of human skin. The most biologically relevant process is the **photoisomerization** from trans‑urocanic acid to cis‑urocanic acid upon exposure to ultraviolet B (UVB) radiation. This reaction does not refer to a specific protein, receptor, or drug target but rather describes a chemical transformation that can occur spontaneously under UV light or be catalyzed by certain microbial enzymes such as *cis*-UCA isomerase in some bacteria[3][6]. Trans‑urocanic acid acts as an endogenous sunscreen, absorbing UVB and protecting against DNA damage; its photoisomerized product, *cis*-urocanic acid, has been shown to activate regulatory T cells and contribute to immunosuppression following sun exposure[1][3]. The balance between these two forms may influence susceptibility to immune-mediated skin conditions. In clinical biochemistry, measurement of this ratio serves as a sensitive indicator for suberythemal UVB doses and sunscreen efficacy assessment[1]. Because "Urocanic acid isomerization" describes a **chemical process** rather than an individual molecular target such as an enzyme or receptor, it should not be considered a therapeutic target itself. Instead, enzymes involved in its metabolism—such as histidine ammonia lyase or microbial *cis*-UCA isomerases—are more appropriate molecular targets if relevant for research purposes[2][3][6].

Other names
Urocanic acid photoisomerizationtrans-urocanic acid to cis-urocanic acid conversioncis-trans urocanic acid isomerization
02

Biological functions

UV-induced photoprotection[1]Immunomodulation via regulatory T cell activation (cis-isomer)[1]Part of histidine catabolism[1][2]
03

Disease associations

Atopic dermatitis and asthma (via filaggrin pathway disruption)[1]Immune suppression after UV exposure[3]
04

Biomarkers

Ratio of cis/trans urocanic acid in skin as a marker for UVB exposure and photoprotection efficacy[1]

Beyond the preview

Go deeper on Urocanic acid isomerization.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urocanic acid isomerization.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call